Search

everythinglearnresearchcommunity

for

Search:↓

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

A woman's male-like physical changes were caused by two rare ovarian conditions.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

Skin symptoms can indicate endocrine disorders and have various treatments.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Fasting in hens affects thyroid hormones, which regulate feather and hair growth.

Early hormones shape sex-specific differences in rat glands.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Acne is an important sign of androgen excess disorders in women.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.